WallStSmart

Ainos Inc (AIMD)vsMKS Instruments Inc (MKSI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 3545494% more annual revenue ($3.93B vs $110,870). MKSI leads profitability with a 7.5% profit margin vs 0.0%. AIMD appears more attractively valued with a PEG of 0.93. MKSI earns a higher WallStSmart Score of 55/100 (C-).

AIMD

Hold

40

out of 100

Grade: D

Growth: 3.3Profit: 2.5Value: 6.7Quality: 6.0
Piotroski: 2/9Altman Z: -3.48

MKSI

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 4.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AIMD.

MKSISignificantly Overvalued (-64.0%)

Margin of Safety

-64.0%

Fair Value

$158.01

Current Price

$243.68

$85.67 premium

UndervaluedFair: $158.01Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIMD2 strengths · Avg: 9.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

PEG RatioValuation
0.938/10

Growing faster than its price suggests

MKSI0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

AIMD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.1%4/10

4.1% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$12.31M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

MKSI4 concerns · Avg: 2.5/10
Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Debt/EquityHealth
1.763/10

Elevated debt levels

P/E RatioValuation
55.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AIMD

The strongest argument for AIMD centers on Price/Book, PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : MKSI

Revenue growth of 10.6% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : AIMD

The primary concerns for AIMD are Revenue Growth, EPS Growth, Market Cap.

Bear Case : MKSI

The primary concerns for MKSI are Profit Margin, Debt/Equity, P/E Ratio. A P/E of 55.9x leaves little room for execution misses. Debt-to-equity of 1.76 is elevated, increasing financial risk.

Key Dynamics to Monitor

AIMD carries more volatility with a beta of 2.37 — expect wider price swings.

MKSI is growing revenue faster at 10.6% — sustainability is the question.

MKSI generates stronger free cash flow (91M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKSI scores higher overall (55/100 vs 40/100) and 10.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ainos Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?